A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts

0 / 5 (0 votos)

The Lancet Haematology

Fecha de publicación: 06 june 2018

DOI: https://doi.org/10.1016/S2352-3026(18)30063-2

Autores: Prof Ingrid Pabinger, MD., Nick van Es, MD., Georg Heinze, PhD., Florian Posch, MD., Julia Riedl, MD., Eva-Maria Reitter, MD., Marcello Di Nisio, MD., Gabriela Cesarman-Maus, MD., Noémie Kraaijpoel, MD,. Prof Christoph Carl Zielinski, MD., Prof Harry Roger Büller, MD., Cihan Ay, MD.

Background: Venous thromboembolism is a common complication of cancer, but the risk of developing venous thromboembolism varies greatly among individuals and depends on numerous factors, including type of cancer. We aimed to develop and externally validate a clinical prediction model for cancer-associated venous thromboembolism.

Seguir leyendo